• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo

An Interview with Irina and Michael Conboy on Blood Factors in Aging


  • Please log in to reply
5 replies to this topic

#1 reason

  • Guardian Reason
  • 1,101 posts
  • 241
  • Location:US

Posted 03 February 2017 - 01:25 PM


Here is a lengthy interview with researchers Irina and Michael Conboy on their work with parabiosis. This involves joining the circulatory systems of an old and a young mouse, and studies have shown that this reverses some measures of aging in the old mouse. Researchers have so far largely focused on the possible effects of signal molecules present in young blood, but the most recent work from the Conboy lab provides fairly compelling evidence to suggest that the more interesting benefits are instead produced by a dilution of harmful signals in old blood. This is reinforced by the possible identification of one of those signals by another research group. In the bigger picture, this means that initiatives involving blood transfusions are probably going to fail, and would explain why transfusions in mice didn't produce noteworthy outcomes. One alternative approach suggested by this new research is plasmapheresis, a class of existing therapy in which blood plasma is replaced in volume, and which would hopefully also dilute harmful signals in the process.

Dan Pardi: In my conversation with Aubrey de Grey, he was optimistic of stem cells being one area in which we can effect aging itself. If we have these stem cells that regenerate and then can become new tissue, what does happen with aging to stem cells?

Irina Conboy: What we believe and we found is that, interestingly, stem cells remain relatively young in a person who is 80, 85 years old. You are like a mosaic of cells. Many of your cells are old, decrepit. They have damaged DNA and short telomeres and what not. But stem cells are actually pretty healthy, and young, and functional. They are inhibited. They are pretty much blocked by their surrounding tissue, called the niche. That niche blocks them from performing any work. The cells that we know work just like keep sleeping and do not repair the tissue. Then, because of that, when there is tissue damage and stem cells are sleeping, they are not activated. Then the damage is not regenerated. Instead you have fibrosis. It's like your plan B. You now make fibrous tissue, and depose fat tissue to replace the damage. Then gradually the time, you just turn into this big scar and big fat blob. Then if you figure that there are proved ways to reawaken stem cells then 70 year old, 80 year old person will start regenerating. All of the organs as if they are 20 year old. Gradually, not only you prevent all these bad diseases to happen but perhaps start getting even younger.

Dan Pardi: One publication that got a lot of attention is one where you did this parabiosis experiment where you had blood exchanged from an old rat to a young rat. Tell us a little bit about that one.

Irina Conboy: In this experiment we found that old animal becomes much younger, with respect to muscle degeneration, formation of new neurons in the brain. Also, liver regeneration. All of these molecules which were responsible for making animal younger were also rejuvenated. It was not just a fluke. There was also fundamental mechanism of how they became younger. The young animals suffered from this connection. Became older, particularly in liver and in brain. From that time on, people kind of became obsessed with the stories about vampires and that young blood holds the secret to health, and youth, and so forth. It was really strange to me. It was surprising that that was such a simplistic interpretation of our findings. Which we did not intend our findings to be interpreted like that. Also, that how much, I guess, interest it got. It really absorbed all of the funding in the area. As a result there was not enough funding to do any alternative work, which in my opinion was the most important work to do. The main secret there is that mice share more than blood when you staple them. When they live together for like an entire month, then old mouse now has access to young heart. The blood pressure becomes better. Young lungs, so now you have better oxygenation of blood. Red blood cells now are more oxygenated. Also, you have young red blood cells going into an old animal. Also, you have young liver. You have much better metabolism. You have young immune system. You have much less inflammation. It is not, you know, those secret proteins in blood. It is simple things like how much oxygen does your brain get. That was completely overlooked.

Dan Pardi: What did you think was going on? What was your next experiment that took it a step further to identify really what was going on?

Michael Conboy: At the time we also would take cells and grow them in culture. Usually when you do that you add some amount of serum to that. That's the liquid fraction of blood. You spin out the cells. If you grow the cells in young serum, they grow very well. If you grow them in old serum, they grow poorly. What was interesting was if we mixed young serum and old serum together, the cells grew poorly. That indicated that there was something that was in the old serum that was suppressing the growth and was also dominate over whatever was in young serum. That got us thinking that what was growing on in parabiosis must be more along on the lines of the young animals filtering some old, inhibitory stuff out of the old mouse. Maybe more than it's adding young positive factors to the mix. That got Irina thinking that there's got to be something that circulates, that's inhibitory, and what could it be?

Irina Conboy: Then, we were thinking about the clear experiment. A proof of principal which we will once and for all discriminate between whether young blood is good or whether we need to remove old blood inhibitors. That's how we switched to the blood exchange. Which is much more difficult to set up than parabiosis. It is much better experimental set up to answer many questions. In blood exchange, in fact, we do exchange only blood. There are small catheters which are inserted into mouse veins. You can imagine, mice are very little, how tiny their veins are. You need to be very, very skilled to be able to catheterize mouse veins. Then there is a pump that pretty much mixes the blood from young mouse with an old mouse to equilibrium. Which is identical to parabiosis. There is no loss of blood. There is no gain of blood. They are mixed in exactly the same way. That happens in one day. Then mice are not living together for one month anymore. They do not share organs. You exchange their blood. Then very quickly you can study what happens with their organs and tissues. Most surprising findings that you have from this experiment is that, yes, blood exchange without any organ sharing or adaptation does have effect on youth and aging. The effect is almost instantaneous. It implies completely different set of mechanisms as compared to when mice are sutured and running together.

Dan Pardi: For humans would be like a dialysis situation. Now you have to just figure out, how frequently? How much needs to be removed and put back in?

Irina Conboy: We have clinical trials under development with our colleague Professor Dobri Kiprov from San Francisco Blood Apheresis Clinic. Who is doing blood exchange in people for 35 years. He contacted us because of reading our papers. Make him interested in can this be repositioned. Repositioning is when you already have FDA approved procedure and your clinical trial therefore are much more advanced. You just see if the same or slightly modified protocol can be used. We do plan to study in those clinical trials how much younger do people become? Do they become younger in their epigenetics for example? Do they become younger in their lack of predisposition to cancer? There are many, many parameters that we can study. How much improvement can we expect from our process or approach where we take person's blood and it goes through the plasmapheresis machine in the approved process?

Link: http://blog.dansplan...th-young-blood/


View the full article at FightAging

#2 pone11

  • Guest
  • 654 posts
  • 157
  • Location:Western US
  • NO

Posted 29 March 2017 - 04:19 AM

I just cannot believe that no one commented on this, and I would argue that the recent research of the Conboys is actually very important work.  The reason is that it might make it possible to apply the results to humans within 10 years.

 

It is much easier to filter plasma of bad metabolites than it is to create metabolites de novo and administer them. If young blood contained metabolites that made old people young, the economics of making that cheaply and the FDA approvals alone would bury the discovery from practical application in humans for 20 years.   GDF11 is a perfect example of that type of approach.  Even if GDF11 had panned out as the garden of eden, how could you expect for large numbers of people to take it without any FDA approvals?

 

On the other hand, if the blood/plasma of old animals simply contains extra metabolites that need filtering, that can be done by existing and approved technology with probably very simple tweaking. This is something that could start being used on a wide scale in humans within 10 years if the plasmapheresis experiments being planned by the Conboys bear out their thesis.

 

This is an incredibly important study and people need to bookmark it and discuss it.

 

Has LongeCity thought about possibly sponsoring any part of the Conboy's human plasmapheresis experiment?   If that experiment pans out, it is going to make national headlines and would be great promotional value for the foundation making the investment.



Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).

#3 pone11

  • Guest
  • 654 posts
  • 157
  • Location:Western US
  • NO

Posted 08 January 2018 - 03:24 AM

Does anyone have an update on the Conboy's plasmapheresis study?   Did this even get funding?



#4 Mind

  • Life Member, Director, Moderator, Treasurer
  • 18,997 posts
  • 2,000
  • Location:Wausau, WI

Posted 08 January 2018 - 07:37 PM

I have not heard anything.



#5 Turnbuckle

  • Location:USA
  • NO

Posted 08 January 2018 - 09:27 PM

 

It is much easier to filter plasma of bad metabolites than it is to create metabolites de novo and administer them.

 

Buying drugs in pills will always be easier than going in to have your blood filtered.



Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).

#6 pone11

  • Guest
  • 654 posts
  • 157
  • Location:Western US
  • NO

Posted 09 January 2018 - 04:21 AM

 

 

It is much easier to filter plasma of bad metabolites than it is to create metabolites de novo and administer them.

 

Buying drugs in pills will always be easier than going in to have your blood filtered.

 

 

I agree.  Of what use is this fact if the availability of the pill requires $200 Million USD of research and 15 years to get an FDA approval?   And what is the cost of that pill, and for what "disease" will it be indicated?

 

The point of plasmapheresis is that the approvals are already in place, and it can, therefore, be therapeutic within the next five years, no matter which specific protein(s) in the blood of aged animals ends up being the offender.



Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).



0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users